2. UroToday Home
  3. Center Of Excellence
  4. Imaging Center
  5. Imaging Center
  6. Video

18F Fluorocholine PET-Whole Body MR in the Staging of High Risk Prostate Cancer - Ur Metser

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • subtitles off, selected

    January 28, 2019

    Ur Metser a study that was conducted to determine whether integrated 18F-fluorocholine (FCH) PET whole-body MRI (PET/WBMRI) depicts lymph node and distant metastases in patients with high-risk prostate cancer more frequently than does conventional staging.

    Biography:

    Ur Metser, MD, FRCPC, Joint Department of Medical Imaging, the University of Toronto

    Related Content:

    18F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer